Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Filings indexed 1,762 across all filing types
Latest filing 2024-11-22 Regulatory Filings
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
General Updates
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to stock exchanges (BSE and NSE) regarding an update on a USFDA inspection of a manufacturing facility. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The letter informs about the issuance of an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) classification and the closure of the inspection. The document is brief (1525 characters) and serves as an official notification or regulatory update rather than a detailed report or financial statement. It does not contain financial data, management discussion, or detailed audit information. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance disclosures that do not fit other specific categories.
2024-11-22 English
Intimation under regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to the stock exchanges (BSE and NSE) regarding an update on the USFDA inspection of a manufacturing facility. It mentions the issuance of an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) classification and the closure of the inspection. The document is brief (1525 characters) and serves as an intimation or announcement under SEBI regulations rather than a detailed report. There are no financial statements, detailed analysis, or comprehensive report content. This fits the profile of a Regulatory Filing (RNS) as it is a regulatory announcement about an inspection outcome, not a full audit report or annual/interim report.
2024-11-22 English
Earning Call Transcript
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchanges (BSE and NSE) regarding the transcript of a conference call with analysts and investors on the financial results for the quarter and half year ended 30th September 2024. It references the transcript being placed on the company's website and is a notification rather than the transcript itself. The document length is short (1503 characters), and it does not contain the actual transcript text but only announces its availability. According to the rules, such announcements of transcripts should be classified as Regulatory Filings (RNS) because it is a regulatory announcement about the transcript, not the transcript itself.
2024-10-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchanges (BSE and NSE) regarding the transcript of a conference call with analysts and investors on the financial results for the quarter and half year ended 30th September 2024. It references the transcript being placed on the company's website and is a notification rather than the transcript itself. The document length is short (1503 characters), and it primarily serves as an announcement of the availability of the transcript, not the transcript content itself. According to the classification rules, a transcript of a conference call is classified as a Call Transcript (CT). However, since this document is only an announcement of the transcript's availability and not the transcript itself, it should be classified as a Regulatory Filing (RNS) as a fallback for such announcements that do not contain the full transcript text.
2024-10-30 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Torrent Investments Pvt Ltd
Regulatory Filings
2024-10-30 English
Audio Recording of Conference call with Analysts / Investors on Financial Results for the quarter and half year ended 30th September, 2024.
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchanges (BSE and NSE) regarding the audio recording of a conference call with analysts and investors about the financial results for the quarter and half year ended 30th September 2024. It references a previous letter and provides a link to the audio recording on the company's website. The document does not contain the transcript itself, nor detailed financial data or analysis. It is essentially an announcement about the availability of the conference call recording. According to the classification rules, announcements about conference call recordings or links to them are best classified as Regulatory Filings (RNS) because they do not contain the full transcript or substantive financial data. The document length is short (1473 characters), supporting that it is an announcement rather than the full call transcript.
2024-10-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.